Literature DB >> 21851998

Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries: a digital reactive hyperemia study.

Paola Gargiulo1, Caterina Marciano, Gianluigi Savarese, Carmen D'Amore, Stefania Paolillo, Giovanni Esposito, Maurizio Santomauro, Fabio Marsico, Donatella Ruggiero, Oriana Scala, Antonio Marzano, Milena Cecere, Laura Casaretti, Pasquale Perrone Filardi.   

Abstract

BACKGROUND: To assess endothelial function (EF) in type 2 diabetic patients with angiographically normal coronaries compared to diabetic patients with obstructive coronary artery disease (CAD) and to non-diabetic patients, with and without CAD.
METHODS: One hundred eighty-three patients undergoing coronary angiography were divided in: group 1 with diabetes mellitus (DM) and CAD (n = 58); group 2 with DM without CAD (n = 58); group 3 with CAD without DM (n = 31) and group 4 without CAD and DM (n = 36). EF was assessed by reactive hyperemia index (RHI) using a fingertip peripheral arterial tonometry and compared to values obtained in 20 healthy volunteers.
RESULTS: RHI was significantly lower in patients with DM compared to patients without DM (1.69 ± 0.38 vs 1.84 ± 0.44; p = 0.019). RHI was comparable among groups 1, 2 and 3, each value being significantly lower compared to group 4 (2 ± 0.44; p<0.001 vs group 1; p<0.005 vs group 2; p<0.002 vs group 3). At multivariate analysis DM and CAD were significant predictors of endothelial dysfunction (ED) (OR = 2.29; p = 0.012; OR = 2.76; p = 0.001, respectively), whereas diabetic patients (n = 116) CAD and glycated haemoglobin (HbA1c) were independent significant predictors of ED (OR = 3.05; p = 0.009; OR = 1.96; p = 0.004, respectively). Diabetic patients with ED (n = 67) had higher levels of HbA1c than diabetic patients with normal endothelial function (7.35 ± 0.97 vs 6.87 ± 0.90; p = 0.008) and RHI inversely correlated to HbA1c (p = 0.02; r = -0.210).
CONCLUSIONS: Diabetic patients with and without CAD show significantly impaired peripheral vascular function compared to non-diabetic patients without CAD. ED in diabetic patients without CAD is comparable to that of patients with CAD but without DM. HbA1c is a weak independent predictor of ED.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21851998     DOI: 10.1016/j.ijcard.2011.07.076

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  Endothelial dysfunction: its clinical value and methods of assessment.

Authors:  Teresa Strisciuglio; Stefania De Luca; Ernesto Capuano; Rossella Luciano; Tullio Niglio; Bruno Trimarco; Gennaro Galasso
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

2.  Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients.

Authors:  Mario Petretta; Wanda Acampa; Stefania Daniele; Maria Piera Petretta; Carmela Nappi; Roberta Assante; Emilia Zampella; Pierluigi Costanzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2012-10-23       Impact factor: 5.952

3.  "Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle".

Authors:  Paola Gargiulo; Pasquale Perrone-Filardi
Journal:  J Nucl Cardiol       Date:  2016-08-02       Impact factor: 5.952

4.  Impaired endothelial function in female adolescents with type 1 diabetes measured by peripheral artery tonometry.

Authors:  Aagje Pareyn; Karel Allegaert; Willeke Asscherickx; Eva Peirsman; Peter Verhamme; Kristina Casteels
Journal:  Eur J Pediatr       Date:  2013-03-23       Impact factor: 3.183

5.  Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatment.

Authors:  Morten Hedetoft; Niels V Olsen; Isabel G Smidt-Nielsen; Anna M Wahl; Anita Bergström; Anders Juul; Ole Hyldegaard
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

6.  Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.

Authors:  Valentina Trimarco; Raffaele Izzo; Eugenio Stabile; Francesco Rozza; Mario Santoro; Maria Virginia Manzi; Federica Serino; Gabriele Giacomo Schiattarella; Giovanni Esposito; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-14

7.  Peripheral arterial tonometry cannot detect patients at low risk of coronary artery disease.

Authors:  M van den Heuvel; O Sorop; P J Musters; R T van Domburg; T W Galema; D J Duncker; W J van der Giessen; K Nieman
Journal:  Neth Heart J       Date:  2015-09       Impact factor: 2.380

8.  Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension.

Authors:  Luciana Neves Cosenso-Martin; Luiz Tadeu Giollo-Júnior; Débora Dada Martineli; Cláudia Bernardi Cesarino; Marcelo Arruda Nakazone; José Paulo Cipullo; José Fernando Vilela-Martin
Journal:  Diabetol Metab Syndr       Date:  2015-08-26       Impact factor: 3.320

Review 9.  Physical activity in the prevention of peripheral artery disease in the elderly.

Authors:  Gabriele G Schiattarella; Cinzia Perrino; Fabio Magliulo; Andreina Carbone; Antonio G Bruno; Michele De Paulis; Antonio Sorropago; Roberto V Corrado; Roberta Bottino; Giovanni Menafra; Raffaele Abete; Evelina Toscano; Giuseppe Giugliano; Bruno Trimarco; Giovanni Esposito
Journal:  Front Physiol       Date:  2014-03-03       Impact factor: 4.566

10.  Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial.

Authors:  José Fernando Vilela-Martin; Luiz Tadeu Giollo-Junior; Gaspar Rogério Chiappa; Gerson Cipriano-Junior; Paulo José Cardoso Vieira; Fábio dos Santos Ricardi; Manoel Ildefonso Paz-Landim; Days Oliveira de Andrade; Elizabeth do Espírito Santo Cestário; Luciana Neves Cosenso-Martin; Juan Carlos Yugar-Toledo; José Paulo Cipullo
Journal:  Trials       Date:  2016-03-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.